West Pharmaceutical Services, Inc. (LON:0ADY)
238.10
-18.08 (-7.06%)
At close: Jan 28, 2026
LON:0ADY Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 791.3 | 484.6 | 853.9 | 894.3 | 762.6 |
Cash & Short-Term Investments | 791.3 | 484.6 | 853.9 | 894.3 | 762.6 |
Cash Growth | 63.29% | -43.25% | -4.52% | 17.27% | 23.90% |
Receivables | 574.4 | 575.8 | 533.5 | 523.7 | 503.6 |
Inventory | 443.9 | 377 | 434.7 | 414.8 | 378.4 |
Other Current Assets | 168.6 | 100.7 | 114.3 | 86.7 | 97.4 |
Total Current Assets | 1,978 | 1,538 | 1,936 | 1,920 | 1,742 |
Property, Plant & Equipment | 1,843 | 1,716 | 1,513 | 1,263 | 1,127 |
Long-Term Investments | 212.3 | 202.1 | 210 | 204.9 | 207.7 |
Goodwill | 109.9 | 106 | 108.5 | 107.3 | 109.9 |
Other Intangible Assets | 7.7 | 10.8 | 15.1 | 18.4 | 23 |
Long-Term Deferred Tax Assets | 38.4 | 26 | 25.7 | 65.6 | 48.5 |
Other Long-Term Assets | 80.1 | 44.6 | 21.3 | 38.4 | 55.9 |
Total Assets | 4,270 | 3,643 | 3,830 | 3,617 | 3,314 |
Accounts Payable | 253.7 | 239.3 | 242.4 | 215.4 | 232.2 |
Accrued Expenses | 135.9 | 138 | 161.3 | 141.1 | 186.1 |
Current Portion of Long-Term Debt | - | - | 134 | 2.2 | 44.2 |
Current Portion of Leases | 22.7 | 18.8 | 17.7 | 16 | 9.3 |
Current Income Taxes Payable | 28.1 | 31.5 | 16.6 | 29.5 | 26.3 |
Current Unearned Revenue | - | 49.6 | 41.7 | 57.3 | 48.7 |
Other Current Liabilities | 214.5 | 73.2 | 58.1 | 57.5 | 47.3 |
Total Current Liabilities | 654.9 | 550.4 | 671.8 | 519 | 594.1 |
Long-Term Debt | 202.8 | 202.6 | 72.8 | 206.7 | 208.8 |
Long-Term Leases | 95.6 | 83.9 | 84.5 | 93 | 63 |
Long-Term Unearned Revenue | - | 3.6 | 12.2 | 10.9 | - |
Pension & Post-Retirement Benefits | 29 | 28.2 | 29.6 | 28.2 | 40.5 |
Long-Term Deferred Tax Liabilities | 23 | 20.5 | 12.7 | 14.3 | 4.9 |
Other Long-Term Liabilities | 88.7 | 71.9 | 64.9 | 59.8 | 67.1 |
Total Liabilities | 1,094 | 961.1 | 948.5 | 931.9 | 978.4 |
Common Stock | 18.8 | 18.8 | 18.8 | 18.8 | 18.8 |
Additional Paid-In Capital | - | 22.1 | 120.2 | 232.2 | 249 |
Retained Earnings | 4,375 | 3,957 | 3,523 | 2,988 | 2,457 |
Treasury Stock | -1,112 | -1,057 | -637.6 | -370.9 | -229.5 |
Comprehensive Income & Other | -105.5 | -258.1 | -143.8 | -183 | -159.6 |
Shareholders' Equity | 3,176 | 2,682 | 2,881 | 2,685 | 2,335 |
Total Liabilities & Equity | 4,270 | 3,643 | 3,830 | 3,617 | 3,314 |
Total Debt | 321.1 | 305.3 | 309 | 317.9 | 325.3 |
Net Cash (Debt) | 470.2 | 179.3 | 544.9 | 576.4 | 437.3 |
Net Cash Growth | 162.24% | -67.09% | -5.46% | 31.81% | 53.87% |
Net Cash Per Share | 6.47 | 2.43 | 7.24 | 7.60 | 5.73 |
Filing Date Shares Outstanding | 72 | 72.3 | 73.3 | 74.14 | 74.28 |
Total Common Shares Outstanding | 72 | 72.3 | 73.5 | 74.1 | 74.2 |
Working Capital | 1,323 | 987.7 | 1,265 | 1,401 | 1,148 |
Book Value Per Share | 44.11 | 37.10 | 39.20 | 36.23 | 31.47 |
Tangible Book Value | 3,058 | 2,566 | 2,757 | 2,559 | 2,203 |
Tangible Book Value Per Share | 42.48 | 35.48 | 37.52 | 34.54 | 29.68 |
Land | - | 27.9 | 33.7 | 29 | 29.3 |
Buildings | - | 916.1 | 771.5 | 663.6 | 644.8 |
Machinery | - | 1,631 | 1,518 | 1,388 | 1,298 |
Construction In Progress | - | 410.8 | 415.2 | 305.9 | 242.7 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.